The Strange Rise of Scromiting — Most Common Among Young, Heavy Cannabis Users







SpaceX and Amazon stand to get about 4% of the nearly $20 billion that states have proposed for rural broadband buildouts, representing roughly 21% of the locations under the federal BEAD program.
The post Final proposals leave SpaceX and Amazon with 4% of $20 billion rural broadband subsidies appeared first on SpaceNews.

This investment follows Washington Harbour’s earlier moves into space technology.
The post Washington Harbour deepens space portfolio with investment in Trusted Space appeared first on SpaceNews.

SpaceX's network is pushing satellite broadband from a niche service into the mainstream and redefining expectations for ubiquitous access.
The post How Starlink’s explosive growth is reshaping connectivity in an increasingly connected world appeared first on SpaceNews.




Welcome, Jared Isaacman. We who love NASA, or at least the idea of NASA, wish you the very best in taking leadership of the great American space agency. You seem to be an agent for change and NASA sorely needs that. Its human spaceflight program, which garners most of its public attention and financial support, […]
The post Welcome, Jared Isaacman appeared first on SpaceNews.

HOUSTON, TX – December 3, 2025 – For more than three decades, Celestis, Inc. has transformed remembrance into exploration, sending the names, ashes, and DNA of pioneers and visionaries into […]
The post Celestis Selects Stoke Space’s Nova for Infinite Flight: Humanity’s Next Deep-Space Memorial Mission appeared first on SpaceNews.


This episode of the Physics World Weekly podcast features Tim Hsieh of Canada’s Perimeter Institute for Theoretical Physics. We explore some of today’s hottest topics in quantum science and technology – including topological phases of matter; quantum error correction and quantum simulation.
Our conversation begins with an exploration of the quirky properties quantum matter and how these can be exploited to create quantum technologies. We look at the challenges that must be overcome to create large-scale quantum computers; and Hsieh reveals which problem he would solve first if he had access to a powerful quantum processor.
This interview was recorded earlier this autumn when I had the pleasure of visiting the Perimeter Institute and speaking to four physicists about their research. This is the third of those conversations to appear on the podcast.
The first interview in this series from the Perimeter Institute was with Javier Toledo-Marín, “Quantum computing and AI join forces for particle physics”; and the second was with Bianca Dittrich, “Quantum gravity: we explore spin foams and other potential solutions to this enduring challenge“.
This episode is supported by the APS Global Physics Summit, which takes place on 15–20 March, 2026, in Denver, Colorado, and online.
The post Building a quantum future using topological phases of matter and error correction appeared first on Physics World.

In this episode, former NASA commercial space division chief Phil McAlister sits down with host David Ariosto for a wide-ranging conversation about the future of human spaceflight, NASA’s internal culture, and the explosive growth of the commercial space sector.
The post The shift that saved American spaceflight appeared first on SpaceNews.


Roscosmos has replaced a cosmonaut assigned to the next Crew Dragon mission to the International Space Station for reasons neither it nor NASA will disclose.
The post Roscosmos replaces cosmonaut on next Crew Dragon mission to ISS appeared first on SpaceNews.

U.S. Space Command’s push for “dynamic space operations” — the ability to maneuver in orbit without worrying about running dry — demands logistics the military has never had.
The post The overlooked space race: keeping satellites alive appeared first on SpaceNews.

The shape and structure of blood cells provide vital indicators for diagnosis and management of blood disease and disorders. Recognizing subtle differences in the appearance of cells under a microscope, however, requires the skills of experts with years of training, motivating researchers to investigate whether artificial intelligence (AI) could help automate this onerous task. A UK-led research team has now developed a generative AI-based model, known as CytoDiffusion, that characterizes blood cell morphology with greater accuracy and reliability than human experts.
Conventional discriminative machine learning models can match human performance at classifying cells in blood samples into predefined classes. But discriminative models, which learn to recognise cell images based on expert labels, struggle with never-before-seen cell types and images from differing microscopes and staining techniques.
To address these shortfalls, the team – headed up at the University of Cambridge, University College London and Queen Mary University of London – created CytoDiffusion around a diffusion-based generative AI classifier. Rather than just learning to separate cell categories, CytoDiffusion models the full range of blood cell morphologies to provide accurate classification with robust anomaly detection.
“Our approach is motivated by the desire to achieve a model with superhuman fidelity, flexibility and metacognitive awareness that can capture the distribution of all possible morphological appearances,” the researchers write.
For AI-based analysis to be adopted in the clinic, it’s essential that users trust a model’s learned representations. To assess whether CytoDiffusion could effectively capture the distribution of blood cell images, the team used it to generate synthetic blood cell images. Analysis by experienced haematologists revealed that these synthetic images were near-indistinguishable from genuine images, showing that CytoDiffusion genuinely learns the morphological distribution of blood cells rather than using artefactual shortcuts.
The researchers used multiple datasets to develop and evaluate their diffusion classifier, including CytoData, a custom dataset containing more than half a million anonymized cell images from almost 3000 blood smear slides. In standard classification tasks across these datasets, CytoDiffusion achieved state-of-the-art performance, matching or exceeding the capabilities of traditional discriminative models.
Effective diagnosis from blood smear samples also requires the ability to detect rare or previously unseen cell types. The researchers evaluated CytoDiffusion’s ability to detect blast cells (immature blood cells) in the test datasets. Blast cells are associated with blood malignancies such as leukaemia, and high detection sensitivity is essential to minimize false negatives.
In one dataset, CytoDiffusion detected blast cells with sensitivity and specificity of 0.905 and 0.962, respectively. In contrast, a discriminative model exhibited a poor sensitivity of 0.281. In datasets with erythroblasts as the abnormal cells, CytoDiffusion again outperformed the discriminative model, demonstrating that it can detect abnormal cell types not present in its training data, with the high sensitivity required for clinical applications.
It’s important that a classification model is robust to different imaging conditions and can function with sparse training data, as commonly found in clinical applications. When trained and tested on diverse image datasets (different hospitals, microscopes and staining procedures), CytoDiffusion achieved state-of-the-art accuracy in all cases. Likewise, after training on limited subsets of 10, 20 and 50 images per class, CytoDiffusion consistently outperformed discriminative models, particularly in the most data-scarce conditions.
Another essential feature of clinical classification tasks, whether performed by a human or an algorithm, is knowing the uncertainty in the final decision. The researchers developed a framework for evaluating uncertainty and showed that CytoDiffusion produced superior uncertainty estimates to human experts. With uncertainty quantified, cases with high certainty could be processed automatically, with uncertain cases flagged for human review.
“When we tested its accuracy, the system was slightly better than humans,” says first author Simon Deltadahl from the University of Cambridge in a press statement. “But where it really stood out was in knowing when it was uncertain. Our model would never say it was certain and then be wrong, but that is something that humans sometimes do.”
Finally, the team demonstrated CytoDiffusion’s ability to create heat maps highlighting regions that would need to change for an image to be reclassified. This feature provides insight into the model’s decision-making process and shows that it understands subtle differences between similar cell types. Such transparency is essential for clinical deployment of AI, making models more trustworthy as practitioners can verify that classifications are based on legitimate morphological features.
“The true value of healthcare AI lies not in approximating human expertise at lower cost, but in enabling greater diagnostic, prognostic and prescriptive power than either experts or simple statistical models can achieve,” adds co-senior author Parashkev Nachev from University College London.
CytoDiffusion is described in Nature Machine Intelligence.
The post Generative AI model detects blood cell abnormalities appeared first on Physics World.
